VALTOCO^® (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

• Main Authors: Elyse M. Cornett (Author), Sam N. Amarasinghe (Author), Alexis Angelette (Author), Tunde Abubakar (Author), Adam M. Kaye (Author), Alan David Kaye (Author), Elisa E. Neuchat (Author), Ivan Urits (Author), Omar Viswanath (Author)
• Format: Book
• Published: MDPI AG, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Valtoco^® is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older. Although IV and rectal diazepam are already used to treat s...